Hailing Guo

Biostatistician
Sanofi, Bridgewater, NJ, USA
Bridgewater, Massachusetts, United States

Presentation(s):

• OC 01.4 - Interim analysis of joint outcomes in adult and adolescent patients with severe hemophilia A receiving efanesoctocog alfa during the phase 3 XTEND-ed long-term extension study

  Saturday, June 22, 2024
  13:45 – 14:00 ICT